Inhibition of hepatocytic protein degradation by methylaminopurines and inhibitors of protein synthesis

A. Kovács, Per O. Seglen

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Nutritional control of protein degradation in isolated rat hepatocytes can take place in the absence of protein synthesis. Suppression of degradation by amino acids (step-up) is unaffected and the enhanced degradation seen upon amino acid deprivation (step-down) is only partially inhibited by cycloheximide at a concentration (10-3 M) which inhibits protein synthesis virtually completely. Protein degradation per se is, however, inhibited by cycloheximide as well as by puromycin, apparently at least in part by mechanisms additional or unrelated to their effect on protein synthesis. Several puromycin analogues (methylaminopurines) are stronger inhibitors of protein degradation than of protein synthesis, most notably puromycin aminonucleoside and 6-dimethylaminopurine riboside (N6, N6-dimethyladenosine). The latter compounds appear to specifically inhibit cellular autophagy, since neither the degradation of endocytosed protein (asialofetuin) nor the extralysosoma (amino acid-, propylamine- and leupeptin-resistant) degradation are affected.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalBBA - General Subjects
Volume676
Issue number2
DOIs
Publication statusPublished - Aug 17 1981

Fingerprint

Protein Synthesis Inhibitors
Proteolysis
Degradation
Puromycin
Cycloheximide
Amino Acids
Proteins
Propylamines
Puromycin Aminonucleoside
Autophagy
Endocytosis
Hepatocytes
Corrosion inhibitors
Rats

Keywords

  • (Rat hapatocyte)
  • Methylaminopurine
  • Protein degradation
  • Protein synthesis inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Medicine(all)

Cite this

Inhibition of hepatocytic protein degradation by methylaminopurines and inhibitors of protein synthesis. / Kovács, A.; Seglen, Per O.

In: BBA - General Subjects, Vol. 676, No. 2, 17.08.1981, p. 213-220.

Research output: Contribution to journalArticle

@article{b9b1f334fa8642cda2916ead431d1ed4,
title = "Inhibition of hepatocytic protein degradation by methylaminopurines and inhibitors of protein synthesis",
abstract = "Nutritional control of protein degradation in isolated rat hepatocytes can take place in the absence of protein synthesis. Suppression of degradation by amino acids (step-up) is unaffected and the enhanced degradation seen upon amino acid deprivation (step-down) is only partially inhibited by cycloheximide at a concentration (10-3 M) which inhibits protein synthesis virtually completely. Protein degradation per se is, however, inhibited by cycloheximide as well as by puromycin, apparently at least in part by mechanisms additional or unrelated to their effect on protein synthesis. Several puromycin analogues (methylaminopurines) are stronger inhibitors of protein degradation than of protein synthesis, most notably puromycin aminonucleoside and 6-dimethylaminopurine riboside (N6, N6-dimethyladenosine). The latter compounds appear to specifically inhibit cellular autophagy, since neither the degradation of endocytosed protein (asialofetuin) nor the extralysosoma (amino acid-, propylamine- and leupeptin-resistant) degradation are affected.",
keywords = "(Rat hapatocyte), Methylaminopurine, Protein degradation, Protein synthesis inhibitor",
author = "A. Kov{\'a}cs and Seglen, {Per O.}",
year = "1981",
month = "8",
day = "17",
doi = "10.1016/0304-4165(81)90189-6",
language = "English",
volume = "676",
pages = "213--220",
journal = "Biochimica et Biophysica Acta - General Subjects",
issn = "0304-4165",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Inhibition of hepatocytic protein degradation by methylaminopurines and inhibitors of protein synthesis

AU - Kovács, A.

AU - Seglen, Per O.

PY - 1981/8/17

Y1 - 1981/8/17

N2 - Nutritional control of protein degradation in isolated rat hepatocytes can take place in the absence of protein synthesis. Suppression of degradation by amino acids (step-up) is unaffected and the enhanced degradation seen upon amino acid deprivation (step-down) is only partially inhibited by cycloheximide at a concentration (10-3 M) which inhibits protein synthesis virtually completely. Protein degradation per se is, however, inhibited by cycloheximide as well as by puromycin, apparently at least in part by mechanisms additional or unrelated to their effect on protein synthesis. Several puromycin analogues (methylaminopurines) are stronger inhibitors of protein degradation than of protein synthesis, most notably puromycin aminonucleoside and 6-dimethylaminopurine riboside (N6, N6-dimethyladenosine). The latter compounds appear to specifically inhibit cellular autophagy, since neither the degradation of endocytosed protein (asialofetuin) nor the extralysosoma (amino acid-, propylamine- and leupeptin-resistant) degradation are affected.

AB - Nutritional control of protein degradation in isolated rat hepatocytes can take place in the absence of protein synthesis. Suppression of degradation by amino acids (step-up) is unaffected and the enhanced degradation seen upon amino acid deprivation (step-down) is only partially inhibited by cycloheximide at a concentration (10-3 M) which inhibits protein synthesis virtually completely. Protein degradation per se is, however, inhibited by cycloheximide as well as by puromycin, apparently at least in part by mechanisms additional or unrelated to their effect on protein synthesis. Several puromycin analogues (methylaminopurines) are stronger inhibitors of protein degradation than of protein synthesis, most notably puromycin aminonucleoside and 6-dimethylaminopurine riboside (N6, N6-dimethyladenosine). The latter compounds appear to specifically inhibit cellular autophagy, since neither the degradation of endocytosed protein (asialofetuin) nor the extralysosoma (amino acid-, propylamine- and leupeptin-resistant) degradation are affected.

KW - (Rat hapatocyte)

KW - Methylaminopurine

KW - Protein degradation

KW - Protein synthesis inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0019481713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019481713&partnerID=8YFLogxK

U2 - 10.1016/0304-4165(81)90189-6

DO - 10.1016/0304-4165(81)90189-6

M3 - Article

C2 - 7260116

AN - SCOPUS:0019481713

VL - 676

SP - 213

EP - 220

JO - Biochimica et Biophysica Acta - General Subjects

JF - Biochimica et Biophysica Acta - General Subjects

SN - 0304-4165

IS - 2

ER -